Klotho Neurosciences (Nasdaq: KLTO)
Biotechnology Research • 
Omaha, Nebraska, United States • 1-10 Employees
Company overview
| Headquarters | Omaha, Nebraska, United States |
| Phone number | +18288888828 |
| Websites | |
| NAICS | 541714 |
| Keywords | Contract Manufacturing, Gene Therapy, Essential Medicines, Biosimilar Biogenerics, Melanocortin Receptor Analogs, Needle-Free Drug Delivery Systems, Recombinant Klotho |
| Founded | 2019 |
| Employees | 1-10 |
| Socials |
Key Contact at Klotho Neurosciences (Nasdaq: KLTO)
Riad El-Dada
Member Board of Directors
About Klotho Neurosciences (Nasdaq: KLTO)
Klotho Neurosciences (Nasdaq: KLTO) is a biopharmaceutical company committed to the development of disease-modifying therapies for age-related cognitive and neurodegenerative disorders.
$
Klotho Neurosciences (Nasdaq: KLTO) revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | $11,000,000 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
Explore Klotho Neurosciences (Nasdaq: KLTO)'s funding history, including investment rounds, total capital raised, and key backers.
Poland
Spain
France
United Kingdom
Frequently asked questions
Klotho Neurosciences (Nasdaq: KLTO) is located in Omaha, Nebraska, US.
You can reach Klotho Neurosciences (Nasdaq: KLTO) at +18288888828.
Klotho Neurosciences (Nasdaq: KLTO) was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.
Klotho Neurosciences (Nasdaq: KLTO) has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
Klotho Neurosciences (Nasdaq: KLTO) has raised a total of $11,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.
4.8
40,000 users
